On August 19, GeLongHui reported that Nanjing Hicin Pharmaceutical (300584.SZ) disclosed the "Pre-disclosure Announcement of Shareholders with More than 5% Shareholding Reducing Shares". Mr. Liu Xiaoquan, a shareholder holding 6,782,608 shares of the company (accounting for 5.65217% of the total share capital of the company), plans to reduce his shareholding of the company by no more than 1,082,700 shares (accounting for 0.90225% of the total share capital of the company) through centralized bidding and bulk trading within three months after 15 trading days from the date of announcement. Currently, Mr. Liu Xiaoquan holds 5,999,908 shares of the company, accounting for 4.99992% of the total share capital of the company, no longer a shareholder with more than 5% shareholding of the company.
Recently, the company received a notice from shareholder Mr. Liu Xiaoquan regarding the expiration of the share reduction plan and the situation of share reduction. Within the period of the share reduction plan, the shareholder reduced the company's shares by a total of 782,700 shares through centralized bidding.